Verition Fund Management LLC bought a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Rating) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 4,827 shares of the biopharmaceutical company’s stock, valued at approximately $966,000. A number of other hedge funds have also […]